George Washington University to Conduct Clinical Trial for COVID-19 Experimental Vaccine

Monday, July 27, 2020
George Washington University to Conduct Clinical Trial for COVID-19 Experimental Vaccine

The George Washington University (GW) announced it will participate in a clinical trial for an investigational COVID-19 vaccine. GW has been selected as one of approximately 90 sites in the U.S. to participate in clinical trials of experimental vaccines and monoclonal antibodies as part of the COVID-19 Prevention Network (CoVPN). Scientists hope the trials will result in new tools to prevent COVID-19.

Read More